Oblique Therapeutics
Edit

Oblique Therapeutics

http://www.obliquet.com/
Last activity: 28.11.2023
Tags:BioTechDevelopmentDrugLifeMedtechScience
Oblique Therapeutics. We focus on developing new antibody medicines in pain and aggressive-metastatic cancer.
Website visits
1.5K
Mentions
7

Investors 3

Mentions in press and media 7

DateTitleDescriptionSource
28.11.2023AAX Biotech forms strategic collaboration with Oblique Thera...AAX Biotech forms strategic collaboration with Oblique Therapeutics for therapeutic antibody develop...news.cisio...
09.11.2022Oblique Therapeutics is delighted to announce the appointmen...Oblique Therapeutics is delighted to announce the appointment of Christer Nordstedt M.D. PhD . as Ch...news.cisio...
14.01.2022Oblique Therapeutics is pleased to announce that the United ...Oblique Therapeutics is pleased to announce that the United States Patent and Trademark Office has g...news.cisio...
15.11.2021Oblique Therapeutics is thrilled to strengthen its commercia...Oblique Therapeutics is thrilled to strengthen its commercial teams to realize its ambitious goals M...news.cisio...
14.10.2021Oblique Therapeutics is excited to present the recent progre...Oblique Therapeutics is excited to present the recent progress on its anti-Thioredoxin mAb program a...news.cisio...
27.09.2021Oblique Therapeutics announces achievement of key milestone ...Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot® pl...news.cisio...
-Targovax and Oblique enter collaboration to target mutant RA...Oslo, Norway, & Gothenburg, Sweden 29 June 2020 – Targovax ASA (OSE: TRVX), a clinical stage imm...healthcap....